{"pub_date": "2016-02-05T00:00:00Z", "subsection_name": null, "lead_paragraph": "Lawmakers questioned drug company executives Thursday, focusing on pricing practices, and criticized Martin Shkreli for refusing to answer questions.", "print_page": "1", "document_type": "article", "byline": {"contributor": "", "person": [{"rank": 1, "organization": "", "lastname": "POLLACK", "firstname": "Andrew", "role": "reported"}, {"rank": 2, "organization": "", "lastname": "HUETTEMAN", "firstname": "Emmarie", "role": "reported"}], "original": "By ANDREW POLLACK and EMMARIE HUETTEMAN"}, "multimedia": [], "section_name": "Business Day", "headline": {"print_headline": "Hearing on Drug Pricing Delivers Spectacle but Few Answers", "main": "Martin Shkreli Invokes the Fifth Amendment During Grilling by Congress"}, "source": "The New York Times", "blog": [], "word_count": "1292", "web_url": "http://www.nytimes.com/2016/02/05/business/drug-prices-valeant-martin-shkreli-congress.html", "slideshow_credits": null, "news_desk": "Business", "type_of_material": "News", "snippet": "Lawmakers questioned drug company executives Thursday, focusing on pricing practices, and criticized Martin Shkreli for refusing to answer questions.", "_id": "56b325bd38f0d82036f0aa60", "abstract": "Former Turing Pharmaceuticals chief executive Martin Shkreli refuses to answer questions during House Committee on Oversight and Government Reform hearing, exercising Fifth Amendment; Shkreli, who faces federal securities fraud charges, endures harsh criticism from lawmakers related to rising drug prices.  ", "keywords": [{"rank": "1", "name": "persons", "value": "Shkreli, Martin (1983- )", "is_major": "Y"}, {"rank": "2", "name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y"}, {"rank": "3", "name": "organizations", "value": "Turing Pharmaceuticals AG", "is_major": "Y"}, {"rank": "4", "name": "subject", "value": "Prices (Fares, Fees and Rates)", "is_major": "N"}, {"rank": "5", "name": "subject", "value": "Generic Brands and Products", "is_major": "N"}, {"rank": "6", "name": "organizations", "value": "House Committee on Oversight and Government Reform", "is_major": "N"}, {"rank": "7", "name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "is_major": "N"}, {"rank": "8", "name": "persons", "value": "Schiller, Howard B", "is_major": "N"}]}